R

Rheumatologische Schwerpunktpraxis | Berlin, Germany

Research site

(Unclaimed)

Location

Bundesallee 104-105, Berlin, Berlin, Germany

Site insights

Top conditions

Top treatments

Tulisokibart

Guselkumab

MK-7240

MK-7240-013

Methotrexate

Celecoxib

MK-7240-014

Filgotinib

Pf-06651600

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Researchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffn...

Enrolling

Radiographic Axial Spondyloarthritis

Drug: Placebo

Drug: Tulisokibart

A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

Researchers are looking for new ways to treat rheumatoid arthritis (RA). Methotrexate (MTX) is a standard (usual) treatment for RA. However, MTX and...

Enrolling

Arthritis, Rheumatoid

Drug: Tulisokibart

Drug: Placebo

A Study of Guselkumab in Participants With Active Psoriatic Arthritis (APEX)

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the...

Active, not recruiting

Arthritis, Psoriatic

Drug: Placebo

Drug: Guselkumab